M-201 (Futuregen)

N/A

Report date: 2021/11/26 17:33:38

Base Information

Drug NameM-201 (Futuregen)
Drug Alias NameM-201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFutureGen Biopharm (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFutureGen Biopharm (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A